Chartist Inc Accelerate Diagnostics, Inc Transaction History

Chartist Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$3.92 - $6.7 $7,538 - $12,884	1,923 Added 2.87%	68,996 $270,000
Q3 2023 Nov 13, 2023	BUY	$0.75 - $7.21 $50,304 - $483,596	67,073 New	67,073 $385,000
Q2 2022 Aug 15, 2022	BUY	$0.54 - $1.41 $35,567 - $92,869	65,865 New	65,865 $65.4 Million
Q1 2022 May 12, 2022	SELL	$1.4 - $5.15 $92,211 - $339,204	-65,865 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.27 - $6.97 $4,696 - $7,667	1,100 Added 1.7%	65,865 $344 Million
Q2 2021 Aug 11, 2021	BUY	$6.81 - $9.23 $441,049 - $597,780	64,765 New	64,765 $522 Million
Q3 2020 Nov 10, 2020	SELL	$9.98 - $18.04 $646,354 - $1.17 Million	-64,765 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$21.1 - $25.15 $1.37 Million - $1.63 Million	64,765	64,765 $1.45 Billion

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Chartist Inc , based on Form 13F filings with the SEC.

Stay updated on Chartist Inc with notifications on news.